| |
| |
|
| Insider
Information: |
Hamilton James C |
| Relationship: |
Chief Discovery/Trans ... |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
204,851 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,531,304 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
204,851 |
|
|
| Total
Value |
$4,531,304 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Discovery/Trans ... |
2024-04-01 |
204,851 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
• – – |
2024-04-01 |
4 |
S |
$28.03 |
$168,180 |
D/D |
(6,000) |
204,851 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
• – – |
2024-01-12 |
4 |
AS |
$36.47 |
$292,904 |
D/D |
(7,940) |
210,851 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2024-01-05 |
4 |
AS |
$34.00 |
$1,130,748 |
D/D |
(32,143) |
218,791 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
250,934 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2024-01-03 |
4 |
AS |
$31.81 |
$202,781 |
D/D |
(6,300) |
175,934 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2023-06-30 |
4 |
S |
$35.53 |
$106,590 |
D/D |
(3,000) |
188,484 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2023-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
205,287 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Discovery/Trans Medicine |
– – – |
2023-01-03 |
4 |
AS |
$37.46 |
$396,738 |
D/D |
(10,338) |
145,287 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2022-01-05 |
4 |
AS |
$60.51 |
$385,773 |
D/D |
(6,250) |
155,625 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2022-01-04 |
4 |
AS |
$64.89 |
$1,268,818 |
D/D |
(19,375) |
161,875 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
181,250 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2021-01-14 |
4 |
S |
$80.97 |
$812,942 |
D/D |
(10,000) |
126,250 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2021-01-06 |
4 |
AS |
$70.89 |
$1,404,276 |
D/D |
(19,375) |
136,250 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2021-01-05 |
4 |
AS |
$71.09 |
$1,405,303 |
D/D |
(19,375) |
155,625 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Senior Vice President |
– – – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
175,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
|
– – – |
2020-10-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,000 |
|
% |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
